What Is a Gastrointestinal Disorder? Types & Symptoms

A gastrointestinal disorder is any condition that disrupts the normal function of the digestive tract, from the esophagus down through the stomach, intestines, and rectum, as well as the accessory organs that support digestion like the liver and pancreas. These disorders range from common, everyday problems like heartburn and bloating to chronic inflammatory diseases and cancers. A large global study found that roughly one in five to two in five adults meets diagnostic criteria for at least one functional gastrointestinal disorder alone, depending on how the survey was conducted, and that does not even count structural conditions like ulcers or inflammatory bowel disease.¹ The sheer variety of conditions under this umbrella can be confusing, so it helps to understand the major categories, what they feel like, and how doctors tell them apart.

Structural Versus Functional Disorders

The broadest way to divide gastrointestinal disorders is into two camps: structural and functional. Structural disorders involve visible, measurable damage or abnormality in the tissues of the digestive tract. Think of an ulcer crater in the stomach lining, an inflamed stretch of colon you can see on a colonoscopy, or a tumor blocking the intestine. Doctors can point to the problem under a microscope or on a scan.

Functional disorders are different. Patients have real, often severe symptoms, but standard tests come back looking normal. Irritable bowel syndrome is the most well-known example. These conditions are now formally called “disorders of gut-brain interaction” because the underlying issue involves faulty communication between the brain and the digestive system, along with problems like heightened sensitivity of the gut nerves, altered motility, shifts in the gut microbiome, and changes in mucosal immune function.² The name change matters because “functional” used to carry an implication that the problem was imaginary. It is not. The biology is real; it just does not leave a mark visible to conventional endoscopy.

Common Upper GI Disorders

Upper gastrointestinal disorders affect the esophagus, stomach, and the first part of the small intestine. The most widespread is gastroesophageal reflux disease, or GERD, which affects roughly one in five adults in high-income countries. The hallmark symptoms are recurrent heartburn and regurgitation, though some people experience less obvious signs like chronic cough or difficulty swallowing. Left unchecked, GERD can lead to inflammation of the esophageal lining, narrowing of the esophagus, and in a small fraction of cases, a precancerous change called Barrett esophagus.³

Peptic ulcer disease is another common upper GI problem. Ulcers are open sores that develop on the inner lining of the stomach or upper small intestine, and they typically cause a gnawing or burning pain in the upper abdomen, sometimes worsened by eating. The bacterium H. pylori is the primary cause of peptic ulcers and also the leading risk factor for stomach cancer, which is why eradicating this infection with antibiotics has become a cornerstone of treatment.⁴ Non-steroidal anti-inflammatory drugs are the other major culprit, damaging the protective mucus barrier that normally shields the stomach from its own acid.

Inflammatory Bowel Disease

Inflammatory bowel disease, or IBD, refers primarily to two chronic conditions: Crohn’s disease and ulcerative colitis. Both involve the immune system attacking the digestive tract, causing inflammation, pain, diarrhea (often bloody), fatigue, and weight loss. They overlap in many ways, but Crohn’s can affect any part of the GI tract from mouth to anus and tends to involve deeper layers of the bowel wall, while ulcerative colitis is confined to the colon and rectum and typically affects only the innermost lining.

Research has increasingly highlighted the role of genetics and the gut’s resident bacteria in triggering these diseases. Genetic alterations can lead to an exaggerated immune response to normal intestinal bacteria, with specific immune pathways now identified in both conditions. Crohn’s disease has been linked to defects in a cellular recycling process called autophagy, while ulcerative colitis has been associated with genetic susceptibility to a leaky intestinal barrier. Despite this progress, a great deal remains unknown about why some people develop IBD and others do not.⁵

Irritable Bowel Syndrome and Functional Disorders

Irritable bowel syndrome is the single most common reason people are referred to a gastroenterologist. It causes abdominal pain tied to changes in bowel habits, whether that is diarrhea, constipation, or an unpredictable mix of both, along with bloating that many patients describe as their most bothersome symptom.⁶ Unlike IBD, IBS does not cause visible inflammation or tissue damage, which is one reason it was historically dismissed.

A central feature of IBS is visceral hypersensitivity: the nerves in the gut respond to normal amounts of gas, stool movement, or stretching as though something harmful is happening. Research in both humans and animal models has documented that inflammatory cells, mast cells, and certain chemical signals are elevated in the gut tissue of people with IBS who have this heightened sensitivity.⁷ In animal studies, transferring specific immune cells from mice with post-infectious IBS into healthy mice produced both increased gut permeability and heightened pain responses, suggesting the immune changes are not just bystanders but active drivers of symptoms.⁸

Beyond IBS, other functional GI disorders include functional dyspepsia (persistent upper abdominal discomfort without an identifiable cause), functional constipation, and functional bloating. Many people have more than one of these at the same time, and they frequently overlap with each other.

Bloating and Gas

Bloating deserves its own mention because it cuts across nearly every GI diagnosis and is one of the most common complaints doctors hear. It can result from excess gas production, slower-than-normal transit of gas through the intestines, or simply a heightened perception of normal amounts of gas in the gut.⁵ Multiple mechanisms have been proposed, including increased luminal contents, impaired clearance of intestinal gas, altered displacement of abdominal volume, and the heightened visceral sensitivity described earlier.⁹

Because so many different mechanisms can produce the same symptom, treating bloating effectively often means figuring out which mechanism dominates in a given person. Someone with slow transit may benefit from a prokinetic drug, while someone with excess fermentation may respond better to dietary changes. Someone whose gut nerves are simply dialing up the volume on normal signals may get the most relief from neuromodulators or psychological therapies.

The Gut-Brain Connection and Stress

The digestive tract has its own extensive nervous system, sometimes called the “second brain,” which communicates in both directions with the central nervous system. Stress exploits this connection in measurable ways. Exposure to psychological or physical stress alters gut motility, ramps up visceral perception, changes digestive secretions, increases intestinal permeability, impairs the gut’s ability to repair itself, and shifts the balance of intestinal bacteria.¹⁰ Mast cells in the gut wall act as key translators of stress signals, releasing inflammatory chemicals and neurotransmitters that can alter how the gut behaves.

The brain’s stress circuitry communicates with the gut through parasympathetic and sympathetic nerve pathways, with a stress hormone called corticotropin-releasing factor (CRF) acting as a central mediator. Different receptors for this hormone have distinct effects: one type speeds up colonic contractions, potentially triggering urgent diarrhea, while the other slows gastric emptying, contributing to nausea and a feeling of fullness.¹¹ This helps explain why anxiety can cause both diarrhea and a loss of appetite at the same time, and why chronic stress is a recognized trigger for flares of IBD, IBS, and GERD alike.

The Role of the Gut Microbiome

The trillions of microbes living in your intestines do not just passively occupy space. They produce short-chain fatty acids and other metabolites that directly influence gut motility, how sensitive your intestinal nerves are, the integrity of the gut barrier, and local immune responses.¹² When the microbial community falls out of balance, a state often called dysbiosis, these protective functions can break down. Dysbiosis has been documented in both functional disorders like IBS and structural ones like IBD, though researchers are still sorting out whether the microbial shift is a cause, a consequence, or both.

Medications can also tip the microbial balance. Anti-inflammatory painkillers and opioids, for instance, alter the gut’s microbial ecosystem through several routes, including changes to intestinal motility, shifts in luminal pH, altered bile acid metabolism, and direct suppression of certain bacterial species. This drug-induced dysbiosis may partly explain why these medications so commonly cause gastrointestinal side effects like nausea, constipation, and stomach pain.

Less Common but Serious Types

Beyond the high-prevalence conditions, several less talked-about GI disorders can be serious. Ischemic bowel disease occurs when blood flow to part of the intestine is reduced, usually due to a clot, a narrowed artery, or low blood pressure during a critical illness. Abdominal pain is the most common presenting symptom across all forms of ischemic bowel disease, and the condition requires urgent treatment because prolonged loss of blood supply can cause tissue death.¹³

Pancreatic insufficiency is another condition that falls under the GI umbrella even though the pancreas is technically an accessory organ. When the pancreas cannot produce enough digestive enzymes, usually after surgery, chronic inflammation, or certain inherited conditions, fat is poorly absorbed. The result is oily, foul-smelling stools, abdominal pain, and progressive weight loss.¹⁴ Enzyme replacement therapy, taken as capsules with meals, can substantially improve these symptoms.

How Doctors Tell GI Disorders Apart

Because so many different conditions produce overlapping symptoms, diagnosis often involves ruling things out as much as confirming them. One of the most useful screening tools in recent years is a stool test for a protein called fecal calprotectin. Calprotectin is released by white blood cells when there is active inflammation in the intestinal wall. In people with IBD, calprotectin levels are dramatically higher than in those with IBS or other non-inflammatory conditions.¹⁵

A systematic review and meta-analysis found that at standard thresholds, this stool test catches roughly 85 to 93% of IBD cases while correctly identifying about 92 to 94% of IBS cases as non-inflammatory.¹⁶¹⁷ In practical terms, a normal calprotectin result in someone with chronic gut symptoms makes IBD unlikely and can spare them a colonoscopy. A high result, on the other hand, signals the need for further investigation.

When direct visualization is needed, endoscopy remains the gold standard. A standard upper endoscopy or colonoscopy lets the doctor see the mucosal surface, take tissue samples, and sometimes treat problems on the spot, like removing polyps or cauterizing a bleeding vessel. Newer techniques like probe-based confocal laser endomicroscopy go a step further, allowing cellular-level imaging during the procedure and potentially catching precancerous changes earlier than conventional biopsies alone.¹⁸

Dietary Approaches That Actually Have Evidence

For functional GI disorders, especially IBS, dietary modification is often the first line of treatment. The low FODMAP diet, which temporarily restricts a group of fermentable carbohydrates found in foods like wheat, onions, garlic, certain fruits, and dairy, has accumulated the strongest evidence base of any dietary intervention for IBS. A systematic review and network meta-analysis found that it ranked first among dietary approaches for improving global IBS symptoms, abdominal pain, and bloating when compared to habitual diet and standard dietary advice.¹⁹

Individual studies have reported that up to 86% of IBS patients experience improvement in symptoms like abdominal pain, bloating, and erratic bowel habits while on the diet.²⁰ A randomized crossover trial confirmed that the low FODMAP version reduced overall symptom severity, pain intensity, and stool frequency compared to a moderate FODMAP version of the diet.²¹

The diet works by reducing the osmotic load and gas production in the lower small intestine and upper colon. It is meant to be temporary: after a strict elimination phase of a few weeks, foods are reintroduced one category at a time to identify personal triggers. Staying on it indefinitely is not recommended because the restricted version can limit the diversity of gut bacteria and may lead to nutritional gaps. Working with a dietitian familiar with the protocol makes a meaningful difference in both outcomes and long-term dietary quality.

Psychological Therapies for Gut Symptoms

Given the gut-brain connection described earlier, it makes sense that therapies targeting the brain side of the equation can improve digestive symptoms. Gut-directed hypnotherapy is the best-studied example. In one long-term follow-up study, about 71% of IBS patients initially responded to a course of hypnotherapy, and of those responders, 81% maintained their improvement over follow-ups ranging from one to more than five years. Quality of life, anxiety, and depression scores also remained significantly better than they were before treatment, and patients reported needing fewer doctor visits and less medication afterward.²²

A randomized controlled trial tested whether group-format hypnotherapy could help patients whose IBS had not responded to standard medical treatment. After treatment, about 61% of those who received gut-directed hypnotherapy improved, compared with roughly 41% of those who received only standard care. The benefit grew over the follow-up period, with about 54% of the hypnotherapy group still improved at 15 months versus 25% of controls.²³ Cognitive behavioral therapy has also shown benefits for IBS, though these sources focus specifically on hypnotherapy.

GI Disorders in Children

Children face their own set of gastrointestinal disorders, some of which are unique to early life. Hirschsprung’s disease is a condition present from birth in which nerve cells are missing from a segment of the bowel, usually the lower colon. Without those nerves, the affected segment cannot relax and pass stool normally, leading to severe constipation or intestinal obstruction. Diagnosis is confirmed by tissue biopsy showing the absence of ganglion cells, and surgical removal of the affected segment is the standard treatment.²⁴

Infantile hypertrophic pyloric stenosis is another condition specific to the first weeks of life. The muscle surrounding the stomach’s outlet thickens, blocking the passage of food into the small intestine. The classic symptom is projectile vomiting after feeds. Research into its nerve supply has found that while the ganglia in the pylorus are present, there are detectable reductions in certain nerve signaling chemicals, suggesting that nerve function is subtly abnormal even though the nerves themselves are not absent.²⁵ Experimental work has shown that destroying the nerve plexus in the pyloric region produces a functional narrowing, but not the distinctive muscular lump seen in human infants, so the full story of what causes pyloric stenosis remains incomplete.²⁶

Functional GI disorders are also common in children. Recurrent abdominal pain in school-age kids often has no identifiable structural cause and is thought to involve the same gut-brain mechanisms seen in adult IBS. As with adults, the absence of visible damage does not mean the pain is fabricated; it means the wiring is handling signals differently.

Who Is More Likely to Be Affected

Functional GI disorders are more common in women than in men. In the Rome Foundation’s global study, women were about 1.3 to 1.7 times more likely than men to meet criteria for a functional GI disorder, depending on the survey method.¹ The sex gap is especially pronounced for IBS and chronic constipation, though it narrows for functional dyspepsia. The difference tends to be larger in people who seek medical care than in the general population, which may reflect both biology and differences in healthcare-seeking behavior.²⁷

These conditions are not confined to wealthy countries, either. While study methods and cultural factors create some variation in reported rates, the overall pattern holds worldwide. People with functional GI disorders consistently report lower quality of life and visit doctors more often, which carries an economic burden that is easy to underestimate because no single episode is dramatic enough to make headlines. The cumulative effect, in missed workdays, medical costs, and reduced daily functioning, is enormous.